Announcements Trials

Browse Landscape

Status

Terminated 2 Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Melanoma 2 Uterine Cervical Neoplasms 1 Solid Tumor, Adult 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuromyelitis Optica 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 1 Myasthenia Gravis 1 Multiple Sclerosis 1 Lung Neoplasms 1 Laryngectomy; Status 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Encephalomyelitis, Acute Disseminated 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms 1 Autoimmune Diseases of the Nervous System 1

Interventions

Cyclophosphamide 76 Docetaxel 69 Capecitabine 64 Trastuzumab 61 Paclitaxel 50 Tamoxifen 46 Epirubicin 46 Letrozole 42 pyrotinib 40 Fulvestrant 36 Doxorubicin 35 Vinorelbine 33 Radiotherapy 32 Carboplatin 31 exemestane 27 Anastrozole 27 Neoadjuvant Therapy 24 Drug Therapy 22 Fluorouracil 21 palbociclib 20 Exercise 19 Chemotherapy, Adjuvant 19 Bevacizumab 18 pertuzumab 16 Goserelin 16 Cisplatin 16 liposomal doxorubicin 15 Mammography 14 Gemcitabine 14 Blood Specimen Collection 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Neoplasms × Data Collection × Clear all

NCT06240195 2024-03-25

BIO-PROSA

Regina Elena Cancer Institute

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡